SiPhox logo

SiPhox Funding & Investors

SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests for disease safely and in a disposable point-of-care and at-home manner. SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.

siphox.bio

Total Amount Raised: $32,800,000

SiPhox Funding Rounds

  • Series A

    $17,000,000

    Series A Investors

    Overlap Holdings
    Shorewind Capital
    Intel Capital
    LongeVC
    Alumni Ventures Group
    Vishal Rao
    Duke Capital Partners
    Umami Capital
    Kortex Ventures
    Khosla Ventures
    Metaplanet Holdings
  • Seed

    $10,000,000

    Seed Investors

    Longevitytech.fund
    Vituity
    Balaji Srinivasan
    Mass. Manufacturing Innovation Initiative
    Y Combinator
    Paul Buchheit
    Bob Lee
    R-Squared Ventures
    Khosla Ventures
    Metaplanet Holdings
  • Seed

    $5,800,000

    Seed Investors

    Bantam Group
    Evan Cheng
    Y Combinator
    Khosla Ventures
    Metaplanet Holdings
Funding info provided by Diffbot.